TIM

(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol

Created:	2008-05-22
Last modified:	2021-03-01

Find Related PDB Entry
3 entries where TIM is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	45
Chiral Atom Count	1
Bond Count	46
Aromatic Bond Count	5

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
Synonyms	Timolol maleate
Systematic Name (OpenEye OEToolkits)	(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
Formula	C₁₃ H₂₄ N₄ O₃ S
Molecular Weight	316.42
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	OC(COc1nsnc1N2CCOCC2)CNC(C)(C)C
SMILES	CACTVS	3.341	CC(C)(C)NC[CH](O)COc1nsnc1N2CCOCC2
SMILES	OpenEye OEToolkits	1.5.0	CC(C)(C)NCC(COc1c(nsn1)N2CCOCC2)O
Canonical SMILES	CACTVS	3.341	CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2
Canonical SMILES	OpenEye OEToolkits	1.5.0	CC(C)(C)NC[C@@H](COc1c(nsn1)N2CCOCC2)O
InChI	InChI	1.03	InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1
InChIKey	InChI	1.03	BLJRIMJGRPQVNF-JTQLQIEISA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00373
Name	Timolol
Groups	approved investigational
Description	Timolol is a nonselective beta-adrenergic antagonist given in an eye drop solution to reduce intraocular pressure, or pressure in the eyes.[L6724] It is also used in tablet form as a drug to treat hypertension.[L6727] Timolol was first approved by the FDA in 1978.[L6724] This drug is marketed by several manufacturers [L6736] and is an effective agent for the management of conditions such as open-angle glaucoma and hypertension.
Synonyms	Timolol maleate Timolol hemihydrate (S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol Timololum Timolol anhydrous Timolol Timololo
Brand Names	Timolol Maleate-EX Brimonidine Tartrate/Timolol Maleate Ag-dorzolamide Timolol Timolol Timolol Maleate Ophthalmic Gel Forming Solution 0.25% Mint-latanoprost/timolol Brimonidine Tartrate and Timolol Maleate Timolol Solution - 0.5% Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% Tim-Dor PF Act Dorzotimolol Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution Ratio-timolol Maleate 0.5% Novo-timol Liq 0.25% Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution Sterile Ophthalmic Solution Blocadren Tab 20mg PMS-dorzolamide-timolol Duotrav Mylan-dorzolamide/timolol Nu-timolol Tab 5mg Dorzolamide Hydrochloride Timolol Maletae Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution Teva-latanoprost-timolol Combigan Med Timolol Liq Oph 0.5% Timpilo 4 Rhoxal-timolol 0.5% Riva-dorzolamide/timolol Novo-timol Liq 0.5% Priva-dorzolamide-timolol Blocadren Tab 10mg Jamp Brimonidine/timolol Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Xalacom Sandoz Dorzolamide/timolol Tim-Lat -PF Dorzolamide-timolol PF Rhoxal-timolol 0.25% T-LO Latanoprost / Timolol Dorzolamide-timolol Timolol Maleate Ophthalmic Solution Dom-timolol Timolol-10 Tab 10mg Ganfort BRIMONIDINE TARTRATE and TIMOLOL MALEATE Cosopt PF Timpilo 2 Sandoz Travoprost / Timolol Pq Dorzolamide hydrochloride and timolol maleate Apo-timop DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE Teva-latanoprost/timolol Duotrav Pq Apo-latanoprost-timop Mylan-timolol Mint-dorzolamide/timolol Odan-timolol Sandoz Timolol Timolol Maleate Ophthalmic Gel Forming Solution, 0.5% Timolol-20 Tab 20mg Med Timolol Liq Oph 0.25% M-dorzolamide-timolol Timolol Maleate Dorzolamide HCl /Timolol Maleate PMS-latanoprost-timolol Dorzolamide Hydrochloride and Timolol Maleate Preservative Free Timolol Maleate Ophthalmic Gel Forming Solution 0.5% Timolol Solution - 0.25% Apo-timop Gel Timoptic in Ocudose Timolol maleate Cosopt M-latanoprost-timolol Nu-timolol Tab 20mg Nu-timolol Tab 10mg Dorzolamide HCl and Timolol Maleate Timolol Hemihydrate Dorzolamide Hydrochloride-timolol Maleate Teva-dorzotimol Med-dorzolamide-timolol Jamp-latanoprost/timolol Betimol Riva-latanoprost/timolol Ratio-timolol Maleate 0.25% Apo-travoprost-timop Pq Jamp-timolol Tim-Brim-Dor PF Dorzolamide and Timolol Eye Drops BP Blocadren Tab 5mg Beta-tim - 0.5% Liq Cosopt Preservative-free Azarga Dorzolamide Hydrochloride-Timolol Maleate Timolol GFS Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution Dorzolamide and Timolol Dorzolamide Hydrochloride and Timolol Maleate Duokopt Med-latanoprost-timolol Timolol hemihydrate Timolol-5 Tab 5mg Brimonidine tartrate and Timolol maleate Tim-Brim-Dor-Lat Timolide Tab Timoptic PF Teva-timolol Istalol Tim-Dor-Lat Apo-dorzo-timop Van-dorzolamide-timolol Beta-tim - 0.25% Liq Sandoz Latanoprost/timolol Sandoz Brimonidine / Timolol Timoptic Latanoprost and Timolol Ophthalmic Solution Timolol Maleate Ophthalmic Gel Forming Solution PMS-timolol Dorzolamide Hydrochloride Timolol Maleate Jamp Dorzolamide-timolol Blocadren Apo-brimonidine-timop Apo-travoprost-timolol Pq Timoptic-XE Mylan-latanoprost/timolol
Indication	Ophthalmic timolol is indicated for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The oral form of this drug is used to treat high blood pressure.[L6724,L6727] In certain cases, timolol is used in the prevention of migraine headaches.[A179530,L6742]
Categories	Adrenergic Antagonists Adrenergic beta-Antagonists Agents causing hyperkalemia Alcohols Amines Amino Alcohols Antiarrhythmic agents Antiglaucoma Preparations and Miotics Antihypertensive Agents Beta Blocking Agents and Thiazides Beta Blocking Agents, Non-Selective Beta Blocking Agents, Non-Selective, and Thiazides Bradycardia-Causing Agents Cardiovascular Agents Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted EENT Drugs, Miscellaneous Hypotensive Agents Morpholines Ophthalmologicals Oxazines P-glycoprotein substrates Potential QTc-Prolonging Agents Propanolamines Propanols QTc Prolonging Agents Sulfur Compounds Thiadiazoles Thiazoles
ATC-Code	C07AA06 S01ED51 C07BA06 C07DA06 S01ED01
CAS number	26839-75-8

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Beta-1 adrenergic receptor	MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESP...	unknown	antagonist
Beta-2 adrenergic receptor	MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFG...	unknown	antagonist
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	substrate
Cytochrome P450 2D6	MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...	unknown	substrate
ATP-dependent translocase ABCB1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
Pharos	CHEMBL499
PubChem	33624
ChEMBL	CHEMBL499
ChEBI	CHEBI:9599
CCDC/CSD	JEYFEY10

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

Prepare Data

Validate Data

Deposit Data

Help and Resources

TIM

(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol

Find Related PDB Entry

Find related ligands:

Chemical Details

Chemical Component Summary

Chemical Descriptors

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Related Resource References